Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China

Medical Oncology

Volumn 28, Issue 3, 2011, Pages 667-672

  Deng, Qinghua ^a   Sheng, Liming ^a   Su, Dan ^a   Zhang, Lizhen ^a   Liu, Peng ^a   Lu, Ke ^a   Ma, Shenglin ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

DNA repair; Lung cancer; Molecular epidemiology; Polymorphism

Indexed keywords

AP ENDONUCLEASE 1; ATM PROTEIN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CHINA; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; IASPP GENE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CHINA; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RISK FACTORS; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 80052473784     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9507-2     Document Type: Article

References (27)

1. A Fernández-Rubio MF López-Cima P González-Arriaga L García-Castro T Pascual, et al. 2008 The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain Lung Cancer 61 309 316 18336951 10.1016/j.lungcan.2008.01.017
2. JM Samet E Avila-Tang P Boffetta LM Hannan S Olivo-Marston, et al. 2009 Lung cancer in never smokers: clinical epidemiology and environmental risk factors Clin Cancer Res 15 5626 5645 19755391 10.1158/1078-0432.CCR-09-0376
3. S Benhamou A Sarasin 2005 ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review Am J Epidemiol 161 1 14 15615908 10.1093/aje/kwi018
4. MR Spitz X Wu Y Wang LE Wang S Shete, et al. 2001 Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients Cancer Res 61 1354 1357 11245433 1:CAS:528:DC%2BD3MXhvVeltr0%3D
5. RT Abraham 2004 PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways DNA Repair (Amst) 3 883 887 10.1016/j.dnarep.2004.04.002 1:CAS:528:DC%2BD2cXmtVeqsbk%3D
6. S Angèle P Romestaing N Moullan M Vuillaume B Chapot, et al. 2003 ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity Cancer Res 63 8717 8725 14695186
7. CL Zuur YJ Simis PE Lansdaal AA Hart CR Rasch, et al. 2007 Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis Int J Radiat Oncol Biol Phys 68 1320 1325 17418969 10.1016/j.ijrobp.2007.01.042 1:CAS:528: DC%2BD2sXos1SgsLc%3D
8. I Hickson Y Zhao CJ Richardson SJ Green NM Martin, et al. 2004 Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM Cancer Res 64 9152 9159 15604286 10.1158/0008-5472.CAN-04-2727 1:CAS:528:DC%2BD2cXhtVOmsb7K
9. MD Rainey ME Charlton RV Stanton MB Kastan 2008 Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation Cancer Res 68 7466 7474 18794134 10.1158/0008-5472.CAN-08-0763 1:CAS:528:DC%2BD1cXhtFWltb7K
10. RV Lord J Brabender D Gandara V Alberola C Camps, et al. 2002 Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer Clin Cancer Res 8 2286 2291 12114432 1:CAS:528:DC%2BD38XmtVWhsLw%3D
11. P Ceppi M Volante S Novello I Rapa KD Danenberg, et al. 2006 ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine Ann Oncol 17 1818 1825 16980606 10.1093/annonc/mdl300 1:STN:280: DC%2BD28jhtlWhug%3D%3D
12. J Lu S Zhang D Chen H Wang W Wu, et al. 2009 Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility FASEB J 23 3459 3469 19541747 10.1096/fj.09-136549 1:CAS:528:DC%2BD1MXht1GjtLfN
13. D Su S Ma P Liu Z Jiang W Lv, et al. 2007 Genetic polymorphisms and treatment response in advanced non-small cell lung cancer Lung Cancer 56 281 288 17222938 10.1016/j.lungcan.2006.12.002
14. S Zienolddiny D Campa H Lind D Ryberg V Skaug, et al. 2006 Polymorphisms of DNA repair genes and risk of non-small cell lung cancer Carcinogenesis 27 560 567 16195237 10.1093/carcin/bgi232 1:CAS:528:DC%2BD28XhvVeltL8%3D
15. H Jo S Kang SI Kim JW Kim NH Park, et al. 2007 The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study Gynecol Obstet Invest 64 84 88 17314486 10.1159/000100008
16. U Vogel I Laros NR Jacobsen BL Thomsen H Bak, et al. 2004 Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer Mutat Res 546 65 74 14757194 1:CAS:528:DC%2BD2cXnvVeisg%3D%3D
17. W Zhou G Liu S Park Z Wang JC Wain, et al. 2005 Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer Cancer Epidemiol Biomarkers Prev 14 2 491 496 15734977 10.1158/1055-9965.EPI-04-0612 1:CAS:528:DC%2BD2MXhs1GhsLY%3D
18. C Kiyohara K Yoshimasu 2007 Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis Int J Med Sci 4 59 71 17299578 1:CAS:528:DC%2BD2sXms1KrsrY%3D
19. J Soukupova P Dundr Z Kleibl P Pohlreich 2008 Contribution of mutations in ATM to breast cancer development in the Czech population Oncol Rep 19 1505 1510 18497957 1:CAS:528:DC%2BD1cXnvVCqs70%3D
20. A Meyer B Wilhelm T Dörk M Bremer R Baumann, et al. 2007 ATM missense variant P1054R predisposes to prostate cancer Radiother Oncol 83 283 288 17502119 10.1016/j.radonc.2007.04.029 1:CAS:528:DC%2BD2sXmsFKhsLs%3D
21. K Einarsdóttir K Humphreys C Bonnard Y Li Y Li, et al. 2007 Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk Hum Mol Genet 16 154 164 17164260 10.1093/hmg/ddl451
22. H Yang MR Spitz DJ Stewart C Lu IP Gorlov, et al. 2007 ATM sequence variants associate with susceptibility to non-small cell lung cancer Int J Cancer 121 2254 2259 17582598 10.1002/ijc.22918 1:CAS:528:DC%2BD2sXht1aisL%2FN
23. MZ Hadi MA Coleman K Fidelis HW Mohrenweiser DM Wilson 3rd 2000 Functional characterization of Ape1 variants identified in the human population Nucleic Acids Res 28 3871 3879 11024165 10.1093/nar/28.20.3871 1:CAS:528:DC%2BD3cXns1amu70%3D
24. YL Lo YS Jou CF Hsiao GC Chang YH Tsai, et al. 2009 A polymorphism in the APE1 gene promoter is associated with lung cancer risk Cancer Epidemiol Biomarkers Prev 18 223 229 19124501 10.1158/1055-9965.EPI-08-0749 1:CAS:528:DC%2BD1MXhvFertQ%3D%3D
25. M Shen SI Berndt N Rothman JL Mumford X He, et al. 2005 Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China Anticancer Res 25 537 542 15816625 1:CAS:528:DC%2BD2MXjsFSgt7c%3D
26. U Vogel A Olsen H Wallin K Overvad A Tjønneland, et al. 2005 Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50 Cancer Detect Prev 29 209 214 15936590 10.1016/j.cdp.2005.01.001 1:CAS:528:DC%2BD2MXms1egsLY%3D
27. MJ Laska BA Nexø K Vistisen HE Poulsen S Loft, et al. 2005 Polymorphisms in RAI and in genes of nucleotide and base excision repair are not associated with risk of testicular cancer Cancer Lett 225 245 251 15885892 10.1016/j.canlet.2005.03.021 1:CAS:528:DC%2BD2MXlsFGiu74%3D